Key facts
- It has raised $9.8M; the latest was Later Stage VC ($1.8M) in Jul 2024.
- Notable investors include SOSV, MedTech Innovator, IndieBio, Texas Medical Center, Hemisphere Ventures — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Senzo Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Senzo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Senzo Health
Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platform utilizes novel technologies to create mobile, point-of-care, and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing, enabling people to put healthcare information directly into their hands to improve their quality of life.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2013
- Employees
- 20
- Website
- senzo.com/
- Ownership
- Privately Held (backing)
Senzo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Senzo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Senzo Health in its N-PORT filings yet. We sweep new filings monthly.